Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?

Cunningham R, Dial S.

J Hosp Infect. 2008 Sep;70(1):1-6. doi: 10.1016/j.jhin.2008.04.023. Review.

PMID:
18602190
4.

Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.

Kim JW, Lee KL, Jeong JB, Kim BG, Shin S, Kim JS, Jung HC, Song IS.

World J Gastroenterol. 2010 Jul 28;16(28):3573-7.

5.

Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.

Kim YG, Graham DY, Jang BI.

J Clin Gastroenterol. 2012 May-Jun;46(5):397-400. doi: 10.1097/MCG.0b013e3182431d78.

PMID:
22298089
6.

Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.

Biswal S.

Biomed J. 2014 Jul-Aug;37(4):178-83. doi: 10.4103/2319-4170.128002. Review.

7.

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.

Aseeri M, Schroeder T, Kramer J, Zackula R.

Am J Gastroenterol. 2008 Sep;103(9):2308-13. doi: 10.1111/j.1572-0241.2008.01975.x.

PMID:
18702653
8.
9.

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.

Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN.

Am J Gastroenterol. 2012 Jul;107(7):1001-10. doi: 10.1038/ajg.2012.179.

PMID:
22710578
10.

Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.

Kaneria MV, Paul S.

J Assoc Physicians India. 2012 Nov;60:26-8.

PMID:
23767199
11.

Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.

Sansone S, Aschbacher R, Staffler M, Bombonato M, Girardi F, Larcher C, Wiedermann CJ.

J Prev Med Hyg. 2009 Jun;50(2):117-20.

PMID:
20099443
12.

Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.

Turco R, Martinelli M, Miele E, Roscetto E, Del Pezzo M, Greco L, Staiano A.

Aliment Pharmacol Ther. 2010 Apr;31(7):754-9. doi: 10.1111/j.1365-2036.2009.04229.x.

13.

Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.

Bauer MP, Goorhuis A, Koster T, Numan-Ruberg SC, Hagen EC, Debast SB, Kuijper EJ, van Dissel JT.

Neth J Med. 2008 May;66(5):207-11. Review.

14.

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

P├ępin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L.

Clin Infect Dis. 2005 Nov 1;41(9):1254-60.

PMID:
16206099
15.

Does PPI therapy predispose to Clostridium difficile infection?

Pant C, Madonia P, Minocha A.

Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):555-7. doi: 10.1038/nrgastro.2009.128.

PMID:
19713988
16.

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.

Choudhry MN, Soran H, Ziglam HM.

QJM. 2008 Jun;101(6):445-8. doi: 10.1093/qjmed/hcn035.

PMID:
18411220
17.

Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.

Al-Tureihi FI, Hassoun A, Wolf-Klein G, Isenberg H.

J Am Med Dir Assoc. 2005 Mar-Apr;6(2):105-8.

PMID:
15871884
18.

Established and potential risk factors for Clostridum difficile infection.

Vaishnavi C.

Indian J Med Microbiol. 2009 Oct-Dec;27(4):289-300. doi: 10.4103/0255-0857.55436. Review.

20.

The management of Clostridium difficile-associated diarrhoea in a community hospital.

Tomkins K, Raynor J, Rothwell L, DeSilva J, Wilson C.

West Indian Med J. 2011 Jan;60(1):57-60.

PMID:
21809713

Supplemental Content

Support Center